Grifols (GRFS) Begins Integration of Talecris Biotherapeutics

June 8, 2011 7:05 AM EDT Send to a Friend
Get Alerts GRFS Hot Sheet
Trade GRFS Now!
Join SI Premium – FREE
Grifols (Nasdaq: GRFS) reports that it has begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1, 2011.

Talecris will adopt the Grifols, Inc. name as the North American corporate subsidiary of Grifols, S.A., the Spanish holding company based in Barcelona, Spain.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Mergers and Acquisitions

Add Your Comment